Treatment of Superior Vena Cava (SVC) Syndrome and Inferior Vena Cava (IVC) Thrombosis in a Patient with Colorectal Cancer: Combination of SVC Stenting and IVC Filter Placement to Palliate Symptoms and Pave the Way for Port Implantation

  • Alexander Sauter
  • Jürgen Triller
  • Felix Schmidt
  • Ralph Kickuth
Case Report

Abstract

Thrombosis of the inferior vena cava is a life-threatening complication in cancer patients leading to pulmonary embolism. These patients can also be affected by superior vena cava syndrome causing dyspnea followed by trunk or extremity swelling. We report the case of a 61-year-old female suffering from an extended colorectal tumor who became affected by both of the mentioned complications. Due to thrombus formation within the right vena jugularis interna, thrombosis of the inferior vena cava, and superior vena cava syndrome, a combined interventional procedure via a left jugular access with stenting of the superior vena cava and filter placement into the inferior vena cava was performed As a consequence, relief of the patient’s symptoms, prevention of pulmonary embolism, and paving of the way for further venous chemotherapy were achieved.

Keywords

Interventional procedures Inferior vena cava filter Pulmonary embolism Superior vena cava syndrome Vena cava stent Venous thrombosis 

References

  1. 1.
    American Cancer Society (2006) Cancer facts and figures 2006. American Cancer Society, Atlanta, GAGoogle Scholar
  2. 2.
    Jaffer AK (2005) Issues in anticoagulant therapy: recent trials start to answer the tough questions. Cleve Clin J Med 72:157–163PubMedCrossRefGoogle Scholar
  3. 3.
    Otten HM, Mathijssen J, ten Cate H, Soesan M, Inghels M, Richel DJ, Prins MH (2004) Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med 164:190–194PubMedCrossRefGoogle Scholar
  4. 4.
    Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846–1850PubMedCrossRefGoogle Scholar
  5. 5.
    Schafer AI, Levine MN, Konkle BA, Kearon C (2003) Thrombotic disorders: diagnosis and treatment. Hematol Am Soc Hematol Educ Program 1:520–539Google Scholar
  6. 6.
    Van Gerpen R, Mast ME (2004) Thromboembolic disorders in cancer. Clin J Oncol Nurs 8:289–299PubMedCrossRefGoogle Scholar
  7. 7.
    Kim SH, Brennan MF, Russo P, Burt ME, Coit DG (1998) The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 82:389–394PubMedCrossRefGoogle Scholar
  8. 8.
    Lee JJ, Kupfer J, Raissi S, Geller SA, Siegel RJ (1998) Rapid extension of left adrenocortical carcinoma into the right atrium. J Am Soc Echocardiogr 11:86–88PubMedCrossRefGoogle Scholar
  9. 9.
    Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS (2003) Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 169:909–916PubMedCrossRefGoogle Scholar
  10. 10.
    Lanciego C, Chacon JL, Julian A, Andrade J, Lopez L, Martinez B, Cruz M, Garcia-Garcia L (2001) Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR 177:585–593PubMedGoogle Scholar
  11. 11.
    Marcy PY, Magne N, Bentolila F, Drouillard J, Bruneton JN, Descamps B (2001) Superior vena cava obstruction: Is stenting necessary? Support Care Cancer 9:103–107PubMedCrossRefGoogle Scholar
  12. 12.
    Trousseau A (1865) Phlegmasia alba dolens. In: Trousseau A (ed) Clinique medicale de l’Hotel-Dieu de Paris, Vol. 3. Balliere, Paris, pp 654–712Google Scholar
  13. 13.
    Saphner T, Tormey DC, Gray R (1991) Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9:286–294PubMedGoogle Scholar
  14. 14.
    Viale PH, Schwartz RN (2004) Venous thromboembolism in patients with cancer. Part II. Current treatment strategies. Clin J Oncol Nurs 8:465–469PubMedCrossRefGoogle Scholar
  15. 15.
    Cunningham RS (2005) Therapeutic options for the treatment of cancer-associated thrombosis. Semin Oncol Nurs 21(Suppl 1):21–40PubMedCrossRefGoogle Scholar
  16. 16.
    Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62:14–31PubMedGoogle Scholar
  17. 17.
    Levitan N., Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78:285–291CrossRefGoogle Scholar
  18. 18.
    Kuzel T, Esparaz B, Green D, Kies M (1990) Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 65:885–889PubMedCrossRefGoogle Scholar
  19. 19.
    Feffer SE, Carmosino LS, Fox RL (1989) Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil. Cancer 63:1303–1307PubMedCrossRefGoogle Scholar
  20. 20.
    Bertomeu MC, Gallo S, Lauri D, Levine MN, Orr FW, Buchanan MR (1990) Chemotherapy enhances endothelial cell reactivity to platelets. Clin Exp Metastasis 8:511–518PubMedCrossRefGoogle Scholar
  21. 21.
    Rodrigues CI, Njo KH, Karim AB (1993) Hypofractionated radiation therapy in the treatment of superior vena cava syndrome. Lung Cancer 10:221–228PubMedCrossRefGoogle Scholar
  22. 22.
    Charnsangavej C, Carrasco CH, Wallace S, Wright KC, Ogawa K, Richli W, Gianturco C (1986) Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology 161:295–298PubMedGoogle Scholar
  23. 23.
    Uberoi R (2006) Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Interv Radiol 29:319–322CrossRefGoogle Scholar
  24. 24.
    Wallace MJ, Jean JL, Gupta S, Eapen GA, Johnson MM, Ahrar K, Madoff DC, Morello FA, Murthy R, Hicks ME (2004) Use of inferior vena caval filters and survival in patients with malignancy. Cancer 101:1902–1907PubMedCrossRefGoogle Scholar
  25. 25.
    Jarrett BP, Dougherty MJ, Calligaro KD (2002) Inferior vena cava filters in malignant disease. J Vasc Surg 36:704–707PubMedGoogle Scholar
  26. 26.
    Henkle G, Kunz P, Funaki B (2004) Patterns of referral for inferior vena caval filtration: delays and their impact. AJR 183:1021–1024PubMedGoogle Scholar
  27. 27.
    Decousus H, Leizorovicz A, Parent F, et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with deep venous thrombosis prevention du risque d’embolie pulmonaire par interruption. Cave Study Group. N Engl J Med 338:409–415PubMedCrossRefGoogle Scholar
  28. 28.
    Hann CL, Streiff MB (2005) The role of vena caval filters in the management of venous thromboembolism. Blood Rev 19:179–202PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Alexander Sauter
    • 1
  • Jürgen Triller
    • 1
  • Felix Schmidt
    • 1
  • Ralph Kickuth
    • 1
  1. 1.Department of Diagnostic, Interventional and Pediatric RadiologyInselspital, University of BerneBerneSwitzerland

Personalised recommendations